Asymchem

Morrisville, United States Founded: 1995 • Age: 31 yrs
APIs and peptides are developed and manufactured by Asymchem.
Request Access

About Asymchem

Asymchem is a company based in Morrisville (United States) founded in 1995.. The company has 48 employees as of December 31, 2022. Asymchem has completed 1 acquisition, including Snapdragon Chemistry. Asymchem operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

  • Headquarter Morrisville, United States
  • Employees 48 as on 31 Dec, 2022
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $330.56 M (USD), Post-IPO

    Feb 17, 2020

  • Investors
  • Employee Count
    48

    as on Dec 31, 2022

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Asymchem
Headcount 5000-10000
Employee Profiles 11
Employee Profiles
People
Hao Hong
CEO & Chairman
People
Rui Yang
Chief Operating Officer
People
Da Zhang
Chief Financial Officer
People
Xiangke Xu
VP, Finance

Unlock access to complete

Funding Insights of Asymchem

  • Total Funding
  • Total Rounds 1
  • Last Round Post-IPO — $330.6M
  • First Round

    (17 Feb 2020)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2020 Amount Post-IPO - Asymchem Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Asymchem

Asymchem has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Hillhouse. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Global private equity investments are managed with long-term focus.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Asymchem

Asymchem has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Snapdragon Chemistry. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Drug discovery and development service provider
2014
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Asymchem

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Asymchem Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Asymchem

Asymchem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Integrated CDMO services for biopharma R&D and manufacturing are offered.
domain founded_year HQ Location
APIs manufacturing and formulation services are provided in therapeutic segments.
domain founded_year HQ Location
APIs and enzymes are manufactured through fermentation by the CDMO.
domain founded_year HQ Location
APIs and finished products are developed and manufactured.
domain founded_year HQ Location
Generic biocatalytic solutions are provided for pharmaceutical applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Asymchem

Frequently Asked Questions about Asymchem

When was Asymchem founded?

Asymchem was founded in 1995 and raised its 1st funding round 25 years after it was founded.

Where is Asymchem located?

Asymchem is headquartered in Morrisville, United States.

How many employees does Asymchem have?

As of Dec 31, 2022, the latest employee count at Asymchem is 48.

What does Asymchem do?

Asymchem is focussed on the process development and commercial manufacturing of APIs and peptides. Their facilities have been approved by USFDA and Australian TGA for API manufacturing and CFDA for drug product manufacturing. They claim that they have an added advantage of in-house raw materials manufacturing, through which they can control availability and lead-times. Asymchem offers services such as process optimization, pilot manufacturing and DMF filing of peptides and peptide containing drugs. They offer FDF services such as Blending, Encapsulation, Granulation wet granulation, roller compaction and fluid bed granulation, Fluid bed drying, Particle coating, Tablet compression, Tablet film coating immediate and modified release film coat for oral solid dosage forms. They also offer pre-formulation, formulation development, analytical services and stability studies. The companys capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, Highly Potent APIs, cryogenic, catalytic hydrogenation, etc.,.

Who are the top competitors of Asymchem?

Asymchem's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

How many acquisitions has Asymchem made?

Asymchem has made 1 acquisition, including Snapdragon Chemistry.

Who are Asymchem's investors?

Asymchem has 1 investor. Key investors include Hillhouse.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available